Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Science Corporation (MSC) is a Canadian analytical services company specializing in the cannabis and psychedelic sectors. The company provides advanced laboratory testing, regulatory compliance support, and data-driven insights to licensed producers and researchers. A key differentiator is its 'M-Lab,' a high-tech mobile laboratory platform designed to provide on-site analytical chemistry and microbiology services for process optimization. Following its acquisition by Adastra Holdings in 2021, MSC continues to offer specialized services including potency testing, contaminant screening, and terpene profiling. The company utilizes state-of-the-art instrumentation, such as mass spectrometry, to ensure product safety and quality in the evolving life sciences market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Science Corporation.